Patents
Patents for C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
12/2010
12/29/2010CN101928306A Preparation method of glucoside cationic surfactant
12/29/2010CN101926780A Freeze-dried preparation of stabilized anthracycline compound
12/29/2010CN101139373B Method for rapid scale extraction and purification of flax lignan
12/29/2010CN101070334B Process for separating tea sapogenin and tea polysaccharide from tea-oil cake
12/29/2010CA2766320A1 Acid-labile trigger units
12/23/2010US20100324280 Sodium absorption inhibitor, potassium absorption inhibitor, phosphorus absorption inhibitor and preventive agent, therapeutic agent and food containing the same
12/23/2010US20100324275 3, 6-o-bridged pyranose inversion compound and process for producing b-o-pyranoside
12/23/2010US20100324274 Novel synthetic ganglioside derivatives and compositions thereof
12/23/2010US20100322958 Modified saccharides
12/23/2010US20100322952 Compositions for and methods of enhancing the immune response to antigens
12/22/2010EP2264179A1 Aminosugar compound and process for production thereof
12/22/2010EP2264043A1 Heterobifunctional pan-selectin inhibitors
12/22/2010EP2262822A1 Alkyl and/or alkenyl ether of aklyl and/or alkenyl(poly)glycosides and use thereof
12/22/2010CN101921299A Novel extraction technology of stevioside
12/22/2010CN101921298A Method for extracting, separating and purifying seco-isolariciresinol diglucoside from linseed cake
12/22/2010CN101921297A Preparation method and use of main ingredient of fragrance releasing agent for tobacco with jasmine fragrance
12/22/2010CN101318955B Method for preparing effective component of kudzu root
12/22/2010CN101175499B Use of lipid conjugates in the treatment of disease
12/22/2010CN101130562B Method for preparing high purity validamycin powder agent
12/22/2010CN101065392B Intraoral pungent substance
12/21/2010US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
12/21/2010US7854934 For treatment of cancer, preferably for prevention of recurrence of cancer, and for inducing antibodies in subject by administering glycopeptides
12/21/2010CA2578171C Alkoxylated sucrose esters composition
12/21/2010CA2351836C Glycosphingolipid
12/16/2010US20100317820 Polyol Functionalized Water Soluble Carbon Nanostructures
12/16/2010US20100317589 Compositions and methods for treatment of multiple sclerosis
12/16/2010US20100317122 New ultra-sensitive chemiluminescent substrates for enzymes and their conjugates
12/16/2010US20100317031 Ultra-sensitive chemiluminescent substrates for enzymes and their conjugates
12/16/2010US20100316748 Management and treatment of benign prostatic hyperplasia
12/16/2010US20100316657 Synthetic Archaeal Glycolipid Adjuvants
12/16/2010US20100316631 Water Soluble Curcumin-Based Compounds
12/15/2010EP2260838A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
12/15/2010CN101918577A Novel aminoglycoside antibiotic, method for producing the same, and pharmaceutical use of the same
12/15/2010CN101918423A Organic compounds
12/15/2010CN101918422A Process for production of ribofuranose derivatives
12/15/2010CN101918033A Increase of immune response and targeting by antigens and/or drug linkage
12/15/2010CN101914127A Separation and preparation method of high-purity DDMP soybean saponin monomer
12/15/2010CN101914126A Preparation method of diammonium glycyrrhizinate salt capable of accurately controlling ammonium radical content
12/15/2010CN101914122A Method for preparing salidroside by utilizing UGT72B14
12/15/2010CN101914121A Method for preparing salidroside by utilizing RsTyrDC
12/15/2010CN101914120A Method for preparing salidroside by utilizing UGT72B14
12/15/2010CN101914119A Preparation method of konjak ceramide reference sample
12/15/2010CN101168551B lousewort lignans compounds, preparation method and application thereof
12/14/2010US7851592 Recombinant check point kinase for use in identifying modulator for use in treatment and prevention of cell proliferative disorders
12/14/2010US7851451 Formulations for mediating inflammatory bowel disorders
12/14/2010US7851450 Gangliosides with a modified acyl function
12/09/2010WO2010139692A2 Antiviral triterpene derivatives
12/09/2010WO2010118951A3 Method for producing monoethylenically unsaturated glycosylamines
12/09/2010WO2010118950A3 Method for producing unsaturated acylamidoalkyl polyhydroxy acid amides
12/09/2010US20100311956 Synthetic amphiphiles for membrane protein manipulation
12/09/2010US20100311680 Synthesis of novel neamine derivatives and use thereof as antibacterial agents
12/09/2010US20100311673 Sulfanyl-tetrahydropyran-based compounds and methods of their use
12/09/2010US20100311652 Genetic marker for use in the treatment of leukemia
12/08/2010EP2258713A1 Antiviral Triterpene Derivatives
12/08/2010EP2257565A2 Agent for preventing or ameliorating skin aging
12/08/2010EP2257564A2 Rebaudioside a derivative products and methods for making
12/08/2010EP1628685B1 Antiviral phosphonate analogs
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1927197B Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus
12/08/2010CN101909439A Method of aralkylation of 4'-hydroxyl group of anthracyclins
12/08/2010CN101906350A Method for extracting grease from oil-tea camellia seed kernel and recovering saponin and saccharide active substances
12/08/2010CN101906129A Method for separating purified saponin
12/08/2010CN101904890A Preparation method, application and QC (Quality Control) detection method of platycodon grandiflorum active site
12/08/2010CN101463055B O-indican compounds, preparation and use thereof
12/08/2010CN101418024B Process for preparing high purity crystal maltitol
12/08/2010CN101157711B Compound having antineoplastic activity and uses thereof
12/08/2010CN101134976B Method for producing validamycin by circulating fermentation
12/08/2010CN101076353B Releasable polymer conjugate based on aliphatic biodegradable joint
12/07/2010US7847075 2-Azapurine compounds and their use
12/07/2010US7846903 cubic liquid crystal formulation containing an amphiphilic compound such as 1-O-(5,9,13-trimethyltetradecyl)erythritol and a drug ( excluding a lysosomal enzyme) or cosmetic embedded in the cubic liquid crystal; time release agent
12/07/2010CA2368850C Methods for the prevention and/or the treatment of glutamate cytotoxicity
12/02/2010WO2010138608A1 Utilization of pharmacological chaperones to improve manufacturing and purification of biologics
12/02/2010WO2010081163A3 Method for 2-sulfation of glycosides
12/02/2010WO2009134570A3 Electrochemical labels derived from siderophores
12/02/2010US20100305030 Nanoparticles of therapeutic agents having low water solubility
12/01/2010EP2254899A1 Blocking the metastasis of cancer cells and the uses of new compounds thereof
12/01/2010EP1399176B1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5
12/01/2010CN101899082A Triterpenoid saponin compound, application and preparation method
12/01/2010CN101899075A Beta-N-glucosylated-alpha-aminophosphonate compound
12/01/2010CN101899074A Preparation method for monosialotetrahexosyl ganglioside and monosialotetrahexosyl ganglioside sodium injection or freeze-dried powder injection
12/01/2010CN101899073A B Methyl-5-deoxidation-(dialkyl phosphate)-5-(dialkyl phosphamide)-2, 3-O-propylidene-belta-D-furanoside-contained compound
12/01/2010CN101543769B Method for preparing amorphous alloy maltose catalyst and application thereof
12/01/2010CN101293904B New compound, preparation method and application thereof
11/2010
11/30/2010US7842791 Dispersible pharmaceutical compositions
11/30/2010US7842677 use in the field of neuroprotection and cancer treatment (neuroblastoma tumors)
11/30/2010CA2299295C Substituted tetrahydropyrane derivatives and method for producing same
11/25/2010US20100298550 Process for production of ribofuranose derivatives
11/25/2010US20100298246 Sulfonated sugar compounds, pharmaceutical compositions which contain the same, and methods of treating tumors with the same
11/25/2010US20100297156 Analogues of phosphatidylinositol mannosides
11/24/2010CN1948248B Wheat bran total alkyl phenol extract and its preparation method and application
11/24/2010CN101896496A Method for producing 4-deoxy-4-fluoro-d-glucose derivative
11/24/2010CN101891796A Preparation method of high-purity soyasaponin monomers
11/24/2010CN101891780A Novel process for purifying lincomycin hydrochloride by utilizing crystal transfer
11/24/2010CN101891779A Process for synthesizing clindamycin phosphate
11/24/2010CN101891778A Process for synthesizing clindamycin hydrochloride
11/24/2010CN101891777A Method for preparing miglitol intermediate N-hydroxyethyl glucosamine
11/24/2010CN101891776A Method for separating cerebroside from sea cucumber by high speed counter current chromatography
11/24/2010CN101891775A 6-hydroxy-2-O-beta-D-glucopyranose base heptane, and preparation method and application thereof
11/23/2010US7838549 adding three or more sugars with high reproducibility, disulfide bond immobilized on protein-analyzing sensor chip; oligoethylene oxide group enables linker cmpd to minimize nonspecific hydrophobic interaction; metal-sulfur bond; 1,2-dithiolane on tri-branched amino acid attached to oligosaccharide; SPR
11/23/2010CA2223989C Prodrugs of pharmaceuticals with improved bioavailability
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 180